Basic information Safety Supplier Related

1-Benzyl-1,4-diazepan-5-one

Basic information Safety Supplier Related

1-Benzyl-1,4-diazepan-5-one Basic information

Product Name:
1-Benzyl-1,4-diazepan-5-one
Synonyms:
  • 1-Benzyl-2,3,6,7-tetrahydro-(1H)-1,4-diazepin-5(4H)-one
  • 1-Benzyl-1,4-diazepan-5-one
  • 1-(phenylmethyl)-1,4-diazepan-5-one
  • 1-Benzyl-1,4-diazepin-5-one
  • 1-Benzyl-5-oxo-1,4-diazepane
  • NSC45105
  • 1-Benzylhomopiperazin-5-one
  • 5H-1,4-Diazepin-5-one, hexahydro-1-(phenylmethyl)-
CAS:
55186-89-5
MF:
C12H16N2O
MW:
204.27
Product Categories:
  • pharmacetical
  • Ring Systems
Mol File:
55186-89-5.mol
More
Less

1-Benzyl-1,4-diazepan-5-one Chemical Properties

Melting point:
115-117°
Boiling point:
379.8±35.0 °C(Predicted)
Density 
1.097±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
16.00±0.20(Predicted)
Appearance
White to off-white Solid
More
Less

Safety Information

HS Code 
2914290090
More
Less

1-Benzyl-1,4-diazepan-5-one Usage And Synthesis

Uses

1-Benzyl-1,4-diazepan-5-one is a diazepane intermediate that can be used as an inhibitor of human nitric oxide synthesis.

Synthesis

3612-20-2

55186-89-5

General procedure for the synthesis of 1-benzyl-1,4-diazepan-5-one from N-benzylpiperidone: [Ref. Example 119]; 1-benzylhexahydro-1H-1,4-diazepan-5-one; [] Concentrated sulfuric acid (25 mL) was slowly added dropwise to a solution of acetic acid (50 mL) of 1-benzyl-4-piperidone (10.14 g) at room temperature followed by a batch at 0 °C Sodium azide (3.880 g) was added. The reaction was carried out at 0 °C for 2 h, followed by warming to 5 °C and stirring for 25 h. The reaction was completed with the addition of sodium hydroxide (3.880 g). Upon completion of the reaction, the reaction mixture was adjusted to alkaline with aqueous sodium hydroxide solution followed by liquid-liquid partition extraction with chloroform. The aqueous layer was further extracted with chloroform. All organic layers were combined, washed with saturated brine, dried over anhydrous sodium sulfate and filtered. The solvent was removed by concentration under reduced pressure and the residue was purified by silica gel column chromatography (eluent: chloroform-methanol gradient) to afford 1-benzyl-1,4-diazepan-5-one as a white solid (5.081 g, 47% yield).1H-NMR (400 MHz, CDCl3) δ: 2.50-2.70 (6H, m), 3.20-3.35 (2H, m) , 3.60 (2H, s), 6.07 (1H, br), 7.20-7.40 (5H, m).MS (ESI) m/z: 205 (M + H)+.

References

[1] Patent: EP1591443, 2005, A1. Location in patent: Page/Page column 72
[2] Tetrahedron Letters, 1991, vol. 32, # 22, p. 2469 - 2470
[3] Patent: WO2012/101654, 2012, A2
[4] Patent: WO2014/16849, 2014, A2

1-Benzyl-1,4-diazepan-5-oneSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Shanghai Sinch Parmaceuticals Tech. Co. Ltd.
Tel
+86-21-54098501
Email
sales@sinch.com.cn